Chemical Structure (Gabapenin 01)
Chemical structure of Gabapentin depicting its cyclohexane ring bonded to amino and carboxyl functional groups.*
Gabapentin Capsule
Product Images NDC 82804-217
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 82804-217). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Gabapenin 02)
A line graph showing a comparison of mean pain scores over an 8-week period between a placebo group and a group taking Gabapentin at 3,600 mg/day. The x-axis represents weeks, including a 4-week dose titration period and a 4-week fixed dose period. The y-axis shows the mean pain score, which decreases for the Gabapentin group while remaining stable for the placebo group.*
Figure 2 (Gabapenin 03)
A line graph depicting mean pain scores over a 7-week period comparing placebo and two doses of gabapentin (1,800 mg/day and 2,400 mg/day). The x-axis represents weeks, divided into a 3-week dose titration period and a 4-week fixed dose period. The y-axis shows mean pain scores, with separate lines for placebo, 1,800 mg/day gabapentin, and 2,400 mg/day gabapentin.*
Figure 3 (Gabapenin 04)
A bar chart comparing study results for gabapentin (GBP) dosages of 1,800 mg, 2,400 mg, and 3,600 mg against placebo (PBO) groups, showing percentage response rates with statistical significance indicated.*
Figure 4 (Gabapenin 05)
A scatter plot showing percent difference on the vertical axis versus daily dose in milligrams on the horizontal axis for Gabapentin. Data points from three studies labeled as STUDY a, STUDY b, and STUDY c are displayed across doses ranging from 600 mg to 1,800 mg.*
82804-217-30 (Image 01)
Label for Gabapentin 300 mg capsules, 30 count, manufactured by CSPC Ouyi Pharmaceutical Co., Ltd. The label indicates the capsules have grey '300 mg' on white body and grey 'OE B57' on a yellow cap, containing white or off-white powder. Packaged by Proficient Rx LP, Thousand Oaks, CA.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
